Empresa Liminal BioSciences Inc. Nyse
Acciones
LMNL
CA53272L2021
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 51 | 14/07/08 | |
Director of Finance/CFO | 51 | 02/03/22 | |
Patrick Sartore
PSD | President | 49 | 01/01/06 |
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/05/19 |
Director/Board Member | 67 | 14/05/14 | |
Shrinal Inamdar
IRC | Investor Relations Contact | - | - |
Marie Iskra
LAW | General Counsel | 48 | 01/09/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/05/19 |
Director/Board Member | 67 | 14/05/14 | |
Alek Krstajic
CHM | Chairman | 60 | 01/09/20 |
Neil Klompas
BRD | Director/Board Member | 52 | 01/05/19 |
Eugene Siklos
BRD | Director/Board Member | 60 | 01/09/20 |
Director/Board Member | 63 | 01/05/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 3 249 534 | 1 258 903 ( 38,74 %) | 0 | 38,74 % |
Información de la empresa
Liminal BioSciences, Inc.
440, boulevard Armand-Frappier Suite 300
H7V 4B4, Laval
+450 781 0115
http://www.liminalbiosciences.com![Dirección Liminal BioSciences Inc.(LMNL)](https://cdn.zonebourse.com/static/address/64156495.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+34,14 % | 51,12 mil M | |
-6,54 % | 39,4 mil M | |
+34,92 % | 38,48 mil M | |
+12,62 % | 26,36 mil M | |
-12,11 % | 26,22 mil M | |
-13,43 % | 20,96 mil M | |
+43,73 % | 14,02 mil M | |
+31,81 % | 12,49 mil M | |
-4,54 % | 11,61 mil M |